COLO-B.CO vs. ABBV
Compare and contrast key facts about Coloplast A/S (COLO-B.CO) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: COLO-B.CO or ABBV.
Correlation
The correlation between COLO-B.CO and ABBV is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
COLO-B.CO vs. ABBV - Performance Comparison
Key characteristics
COLO-B.CO:
-0.22
ABBV:
0.62
COLO-B.CO:
-0.16
ABBV:
0.94
COLO-B.CO:
0.98
ABBV:
1.14
COLO-B.CO:
-0.17
ABBV:
0.81
COLO-B.CO:
-0.47
ABBV:
1.87
COLO-B.CO:
10.45%
ABBV:
8.21%
COLO-B.CO:
21.58%
ABBV:
24.70%
COLO-B.CO:
-43.67%
ABBV:
-45.09%
COLO-B.CO:
-26.84%
ABBV:
-4.50%
Fundamentals
COLO-B.CO:
DKK 179.53B
ABBV:
$340.83B
COLO-B.CO:
DKK 21.72
ABBV:
$2.39
COLO-B.CO:
36.68
ABBV:
80.70
COLO-B.CO:
2.70
ABBV:
2.59
COLO-B.CO:
DKK 27.45B
ABBV:
$41.23B
COLO-B.CO:
DKK 18.52B
ABBV:
$30.76B
COLO-B.CO:
DKK 6.46B
ABBV:
$17.62B
Returns By Period
In the year-to-date period, COLO-B.CO achieves a 0.97% return, which is significantly lower than ABBV's 9.56% return. Over the past 10 years, COLO-B.CO has underperformed ABBV with an annualized return of 7.09%, while ABBV has yielded a comparatively higher 16.96% annualized return.
COLO-B.CO
0.97%
-1.76%
-13.37%
-8.91%
-2.19%
7.09%
ABBV
9.56%
12.42%
-0.31%
12.63%
20.48%
16.96%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
COLO-B.CO vs. ABBV — Risk-Adjusted Performance Rank
COLO-B.CO
ABBV
COLO-B.CO vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Coloplast A/S (COLO-B.CO) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
COLO-B.CO vs. ABBV - Dividend Comparison
COLO-B.CO's dividend yield for the trailing twelve months is around 2.77%, less than ABBV's 3.26% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO-B.CO Coloplast A/S | 2.77% | 2.80% | 2.72% | 2.46% | 1.65% | 1.94% | 2.06% | 2.64% | 3.04% | 2.83% | 2.24% | 2.31% |
ABBV AbbVie Inc. | 3.26% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
COLO-B.CO vs. ABBV - Drawdown Comparison
The maximum COLO-B.CO drawdown since its inception was -43.67%, roughly equal to the maximum ABBV drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for COLO-B.CO and ABBV. For additional features, visit the drawdowns tool.
Volatility
COLO-B.CO vs. ABBV - Volatility Comparison
The current volatility for Coloplast A/S (COLO-B.CO) is 5.83%, while AbbVie Inc. (ABBV) has a volatility of 7.30%. This indicates that COLO-B.CO experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
COLO-B.CO vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Coloplast A/S and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities